| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 1.15e-06 | 3 | 210 | 3 | GO:0005220 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | MCF2L2 RABGAP1 TBC1D8B ASAP2 MCF2L PREX1 RANBP2 RASGRF1 KALRN DOCK8 ARHGAP10 ASAP3 DENND3 CCDC88C DENND2C ARHGEF26 ARHGAP45 SPATA13 | 7.40e-06 | 507 | 210 | 18 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | MCF2L2 RABGAP1 TBC1D8B ASAP2 MCF2L PREX1 RANBP2 RASGRF1 KALRN DOCK8 ARHGAP10 ASAP3 DENND3 CCDC88C DENND2C ARHGEF26 ARHGAP45 SPATA13 | 7.40e-06 | 507 | 210 | 18 | GO:0030695 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 3.24e-05 | 18 | 210 | 4 | GO:0015278 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | MCF2L2 MCF2L PREX1 RASGRF1 KALRN DOCK8 DENND3 CCDC88C DENND2C ARHGEF26 SPATA13 | 3.51e-05 | 231 | 210 | 11 | GO:0005085 |
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 5.28e-05 | 39 | 210 | 5 | GO:0000993 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 6.21e-05 | 65 | 210 | 6 | GO:0070063 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | HAUS6 CORO1C SPTBN2 HSPH1 BBS4 GC RABGAP1 POF1B EFHC1 SYNE2 DLEC1 DNM1 FMNL1 MTUS2 DNM2 SYNE1 CAPZA2 FMNL3 LIMD2 CCDC88C XIRP2 MACO1 DNM3 CEP295 FSCN1 CDK5 | 9.42e-05 | 1099 | 210 | 26 | GO:0008092 |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 1.06e-04 | 45 | 210 | 5 | GO:0043175 | |
| GeneOntologyMolecularFunction | cyclase activity | 1.07e-04 | 24 | 210 | 4 | GO:0009975 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 1.26e-04 | 25 | 210 | 4 | GO:0016849 | |
| GeneOntologyMolecularFunction | actin filament binding | CORO1C SPTBN2 POF1B FMNL1 SYNE1 CAPZA2 FMNL3 LIMD2 XIRP2 FSCN1 | 1.51e-04 | 227 | 210 | 10 | GO:0051015 |
| GeneOntologyMolecularFunction | tubulin binding | HAUS6 HSPH1 BBS4 RABGAP1 EFHC1 DLEC1 DNM1 MTUS2 DNM2 CCDC88C MACO1 DNM3 CEP295 CDK5 | 1.85e-04 | 428 | 210 | 14 | GO:0015631 |
| GeneOntologyMolecularFunction | intramolecular transferase activity | 2.30e-04 | 29 | 210 | 4 | GO:0016866 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.99e-04 | 31 | 210 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 3.83e-04 | 33 | 210 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 3.83e-04 | 14 | 210 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 6.51e-04 | 66 | 210 | 5 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 6.51e-04 | 66 | 210 | 5 | GO:0001098 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 8.33e-04 | 18 | 210 | 3 | GO:0004016 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 1.08e-03 | 5 | 210 | 2 | GO:0008294 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 1.08e-03 | 5 | 210 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 1.52e-03 | 22 | 210 | 3 | GO:0050998 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase binding | 1.97e-03 | 24 | 210 | 3 | GO:0120283 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | URI1 MCF2L2 RABGAP1 TBC1D8B BIRC6 ASAP2 SERPINB9 PPP4R3C MCF2L PZP PREX1 RANBP2 RASGRF1 KALRN DOCK8 ARHGAP10 ASAP3 DGKZ DENND3 CCDC88C PPP4R3B DENND2C ARHGEF26 ARHGAP45 DNAJC3 SLX4 SPATA13 | 1.99e-03 | 1418 | 210 | 27 | GO:0030234 |
| GeneOntologyMolecularFunction | alpha-tubulin binding | 2.17e-03 | 52 | 210 | 4 | GO:0043014 | |
| GeneOntologyMolecularFunction | D2 dopamine receptor binding | 2.23e-03 | 7 | 210 | 2 | GO:0031749 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.45e-03 | 129 | 210 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | dopamine receptor binding | 2.49e-03 | 26 | 210 | 3 | GO:0050780 | |
| GeneOntologyBiologicalProcess | actin filament-based process | MYOM1 CORO1C SPTBN2 BBS4 POF1B SYNE2 SCN10A PKP2 PREX1 FMNL1 DNM2 CALR MINK1 CAPZA2 ASAP3 CASP5 CDC42BPB FMNL3 LIMD2 CCDC88C XIRP2 POTEJ FSCN1 CDK5 | 1.62e-05 | 912 | 207 | 24 | GO:0030029 |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | SPTBN2 BBS4 RABGAP1 CNOT6 SYNE2 PIP4K2B DNM2 SYNE1 CNOT6L CEP295 TMEM39A FSCN1 | 2.77e-05 | 280 | 207 | 12 | GO:1902115 |
| GeneOntologyBiologicalProcess | maintenance of location in cell | BBS4 POLR2M ADCY6 RYR3 ITPR1 ITPR2 ITPR3 PKP2 CALR SYNE1 CDK5 | 6.49e-05 | 259 | 207 | 11 | GO:0051651 |
| GeneOntologyBiologicalProcess | cyclic nucleotide biosynthetic process | 7.51e-05 | 23 | 207 | 4 | GO:0009190 | |
| GeneOntologyBiologicalProcess | cerebellar cortex development | 7.91e-05 | 71 | 207 | 6 | GO:0021695 | |
| GeneOntologyBiologicalProcess | cortical actin cytoskeleton organization | 8.55e-05 | 45 | 207 | 5 | GO:0030866 | |
| GeneOntologyBiologicalProcess | cerebellar cortex morphogenesis | 1.17e-04 | 48 | 207 | 5 | GO:0021696 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | CORO1C BBS4 RABGAP1 TBC1D8B ASAP2 PREX1 RASGRF1 KALRN DOCK8 ASAP3 ARHGEF26 ARHGAP45 | 1.53e-04 | 335 | 207 | 12 | GO:0043087 |
| GeneOntologyBiologicalProcess | cAMP biosynthetic process | 1.55e-04 | 11 | 207 | 3 | GO:0006171 | |
| GeneOntologyBiologicalProcess | synaptic vesicle budding from presynaptic endocytic zone membrane | 1.55e-04 | 11 | 207 | 3 | GO:0016185 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYOM1 CORO1C SPTBN2 BBS4 POF1B PREX1 FMNL1 DNM2 CALR MINK1 CAPZA2 ASAP3 CASP5 CDC42BPB FMNL3 LIMD2 XIRP2 POTEJ FSCN1 CDK5 | 1.79e-04 | 803 | 207 | 20 | GO:0030036 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | CORO1C TBC1D8B ASAP2 PREX1 RASGRF1 KALRN DOCK8 ASAP3 ARHGEF26 ARHGAP45 | 1.87e-04 | 244 | 207 | 10 | GO:0043547 |
| GeneOntologyBiologicalProcess | synaptic vesicle transport | 2.06e-04 | 54 | 207 | 5 | GO:0048489 | |
| GeneOntologyCellularComponent | lamellipodium | CORO1C SYNE2 NHS MCF2L DNM2 NRBP1 DOCK8 DGKZ CDC42BPB FSCN1 SPATA13 CDK5 | 4.49e-06 | 230 | 213 | 12 | GO:0030027 |
| GeneOntologyCellularComponent | supramolecular fiber | HAUS6 MYOM1 CORO1C HSPH1 POLR2M POF1B RYR3 EFHC1 FBXO22 SYNE2 PKP2 DNM1 DEK MTUS2 DNM2 SYNE1 DNAH2 EFHC2 XIRP2 DNM3 CEP295 POTEJ SPAG17 TUBE1 CDK5 PCNT DNAH11 | 7.03e-05 | 1179 | 213 | 27 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | HAUS6 MYOM1 CORO1C HSPH1 POLR2M POF1B RYR3 EFHC1 FBXO22 SYNE2 PKP2 DNM1 DEK MTUS2 DNM2 SYNE1 DNAH2 EFHC2 XIRP2 DNM3 CEP295 POTEJ SPAG17 TUBE1 CDK5 PCNT DNAH11 | 7.87e-05 | 1187 | 213 | 27 | GO:0099081 |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 8.37e-05 | 9 | 213 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 1.62e-04 | 11 | 213 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | cell leading edge | CORO1C SYNE2 NHS MCF2L DNM2 NRBP1 DOCK8 ASAP3 DGKZ CDC42BPB FSCN1 ARHGEF26 ARHGAP45 SPATA13 CDK5 | 2.00e-04 | 500 | 213 | 15 | GO:0031252 |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 2.82e-04 | 88 | 213 | 6 | GO:0016529 | |
| GeneOntologyCellularComponent | microtubule | HAUS6 HSPH1 EFHC1 DNM1 MTUS2 DNM2 DNAH2 EFHC2 DNM3 CEP295 SPAG17 TUBE1 CDK5 PCNT DNAH11 | 3.93e-04 | 533 | 213 | 15 | GO:0005874 |
| GeneOntologyCellularComponent | AP-5 adaptor complex | 6.12e-04 | 4 | 213 | 2 | GO:0044599 | |
| GeneOntologyCellularComponent | coated membrane | 7.63e-04 | 106 | 213 | 6 | GO:0048475 | |
| GeneOntologyCellularComponent | membrane coat | 7.63e-04 | 106 | 213 | 6 | GO:0030117 | |
| GeneOntologyCellularComponent | sarcoplasm | 1.12e-03 | 114 | 213 | 6 | GO:0016528 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 1.21e-03 | 78 | 213 | 5 | GO:0001917 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 1.22e-03 | 46 | 213 | 4 | GO:0005790 | |
| GeneOntologyCellularComponent | protein phosphatase 4 complex | 1.51e-03 | 6 | 213 | 2 | GO:0030289 | |
| Domain | - | SPTBN2 MCF2L2 RABGAP1 MTMR10 ASAP2 MCF2L DNM1 PREX1 DNM2 GULP1 RANBP2 RASGRF1 KALRN ARHGAP10 ASAP3 APBA1 PLEKHD1 CDC42BPB PPP4R3B DNM3 ARHGEF26 SPATA13 | 6.10e-10 | 391 | 210 | 22 | 2.30.29.30 |
| Domain | PH_dom-like | SPTBN2 MCF2L2 RABGAP1 MTMR10 ASAP2 MCF2L DNM1 PREX1 DNM2 GULP1 RANBP2 RASGRF1 KALRN ARHGAP10 ASAP3 APBA1 PLEKHD1 CDC42BPB PPP4R3B DNM3 ARHGEF26 SPATA13 | 3.00e-09 | 426 | 210 | 22 | IPR011993 |
| Domain | PH | SPTBN2 ASAP2 MCF2L DNM1 PREX1 DNM2 RASGRF1 KALRN ARHGAP10 ASAP3 PLEKHD1 CDC42BPB DNM3 ARHGEF26 SPATA13 | 5.08e-08 | 229 | 210 | 15 | PF00169 |
| Domain | PH | SPTBN2 MCF2L2 ASAP2 MCF2L DNM1 PREX1 DNM2 RASGRF1 KALRN ARHGAP10 ASAP3 PLEKHD1 CDC42BPB DNM3 ARHGEF26 SPATA13 | 1.08e-07 | 278 | 210 | 16 | SM00233 |
| Domain | PH_DOMAIN | SPTBN2 MCF2L2 ASAP2 MCF2L DNM1 PREX1 DNM2 RASGRF1 KALRN ARHGAP10 ASAP3 PLEKHD1 CDC42BPB DNM3 ARHGEF26 SPATA13 | 1.14e-07 | 279 | 210 | 16 | PS50003 |
| Domain | PH_domain | SPTBN2 MCF2L2 ASAP2 MCF2L DNM1 PREX1 DNM2 RASGRF1 KALRN ARHGAP10 ASAP3 PLEKHD1 CDC42BPB DNM3 ARHGEF26 SPATA13 | 1.20e-07 | 280 | 210 | 16 | IPR001849 |
| Domain | RIH_assoc-dom | 2.29e-07 | 6 | 210 | 4 | IPR013662 | |
| Domain | Ins145_P3_rec | 2.29e-07 | 6 | 210 | 4 | PF08709 | |
| Domain | RIH_assoc | 2.29e-07 | 6 | 210 | 4 | PF08454 | |
| Domain | RIH_dom | 2.29e-07 | 6 | 210 | 4 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 2.29e-07 | 6 | 210 | 4 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 2.29e-07 | 6 | 210 | 4 | IPR015925 | |
| Domain | - | 2.29e-07 | 6 | 210 | 4 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 2.29e-07 | 6 | 210 | 4 | PF01365 | |
| Domain | SPEC | 1.34e-06 | 32 | 210 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.34e-06 | 32 | 210 | 6 | IPR018159 | |
| Domain | InsP3_rcpt-bd | 1.40e-06 | 3 | 210 | 3 | IPR000493 | |
| Domain | MIR | 3.09e-06 | 10 | 210 | 4 | PF02815 | |
| Domain | MIR_motif | 3.09e-06 | 10 | 210 | 4 | IPR016093 | |
| Domain | MIR | 3.09e-06 | 10 | 210 | 4 | PS50919 | |
| Domain | MIR | 3.09e-06 | 10 | 210 | 4 | SM00472 | |
| Domain | Znf_C2H2-like | ZNF326 ZBTB48 KLF14 POGZ PRDM2 SALL1 ZNF550 ZBTB21 ZNF615 ZNF860 ZNF468 ZNF418 ZNF607 SALL4 ZNF510 ZNF501 ZNF28 ZNF92 ZNF540 ZFHX2 ZNF808 ZNF761 ZNF99 ZNF415 ZNF654 | 3.54e-06 | 796 | 210 | 25 | IPR015880 |
| Domain | zf-C2H2 | ZBTB48 KLF14 POGZ PRDM2 SALL1 ZNF550 ZBTB21 ZNF615 ZNF860 ZNF468 ZNF418 ZNF607 SALL4 ZNF510 ZNF501 ZNF28 ZNF92 ZNF540 ZFHX2 ZNF808 ZNF761 ZNF99 ZNF415 | 3.63e-06 | 693 | 210 | 23 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZBTB48 KLF14 PRDM2 SALL1 ZNF550 ZBTB21 ZNF615 ZNF860 ZNF468 ZNF418 ZNF607 SALL4 ZNF510 ZNF501 ZNF28 ZNF92 ZNF540 ZFHX2 ZNF808 ZNF761 ZNF99 ZNF415 ZNF654 | 3.72e-06 | 694 | 210 | 23 | IPR013087 |
| Domain | Znf_C2H2 | ZNF326 ZBTB48 KLF14 POGZ PRDM2 SALL1 ZNF550 ZBTB21 ZNF615 ZNF860 ZNF468 ZNF418 ZNF607 SALL4 ZNF510 ZNF501 ZNF28 ZNF92 ZNF540 ZFHX2 ZNF808 ZNF761 ZNF99 ZNF415 ZNF654 | 4.31e-06 | 805 | 210 | 25 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF326 ZBTB48 KLF14 POGZ PRDM2 SALL1 ZNF550 ZBTB21 ZNF615 ZNF860 ZNF468 ZNF418 ZNF607 SALL4 ZNF510 ZNF501 ZNF28 ZNF92 ZNF540 ZFHX2 ZNF808 ZNF761 ZNF99 ZNF415 ZNF654 | 4.60e-06 | 808 | 210 | 25 | SM00355 |
| Domain | Spectrin | 4.89e-06 | 23 | 210 | 5 | PF00435 | |
| Domain | DH_1 | 6.67e-06 | 63 | 210 | 7 | PS00741 | |
| Domain | ZINC_FINGER_C2H2_2 | ZBTB48 KLF14 POGZ PRDM2 SALL1 ZNF550 ZBTB21 ZNF615 ZNF860 ZNF468 ZNF418 ZNF607 SALL4 ZNF510 ZNF501 ZNF28 ZNF92 ZNF540 ZFHX2 ZNF808 ZNF761 ZNF99 ZNF415 ZNF654 | 7.14e-06 | 775 | 210 | 24 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZBTB48 KLF14 POGZ PRDM2 SALL1 ZNF550 ZBTB21 ZNF615 ZNF860 ZNF468 ZNF418 ZNF607 SALL4 ZNF510 ZNF501 ZNF28 ZNF92 ZNF540 ZFHX2 ZNF808 ZNF761 ZNF99 ZNF415 ZNF654 | 7.45e-06 | 777 | 210 | 24 | PS00028 |
| Domain | - | ZBTB48 PRDM2 SALL1 ZNF550 ZBTB21 ZNF615 ZNF860 ZNF468 ZNF418 ZNF607 SALL4 ZNF510 ZNF501 ZNF28 ZNF92 ZNF540 ZFHX2 ZNF808 ZNF761 ZNF99 ZNF415 ZNF654 | 8.74e-06 | 679 | 210 | 22 | 3.30.160.60 |
| Domain | RhoGEF | 1.11e-05 | 68 | 210 | 7 | SM00325 | |
| Domain | RhoGEF | 1.35e-05 | 70 | 210 | 7 | PF00621 | |
| Domain | DH_2 | 1.35e-05 | 70 | 210 | 7 | PS50010 | |
| Domain | - | 1.49e-05 | 71 | 210 | 7 | 1.20.900.10 | |
| Domain | DH-domain | 1.49e-05 | 71 | 210 | 7 | IPR000219 | |
| Domain | Spectrin_repeat | 1.63e-05 | 29 | 210 | 5 | IPR002017 | |
| Domain | Dynamin_central | 2.73e-05 | 6 | 210 | 3 | IPR000375 | |
| Domain | GED | 2.73e-05 | 6 | 210 | 3 | SM00302 | |
| Domain | Dynamin_M | 2.73e-05 | 6 | 210 | 3 | PF01031 | |
| Domain | GED_dom | 2.73e-05 | 6 | 210 | 3 | IPR020850 | |
| Domain | GED | 2.73e-05 | 6 | 210 | 3 | PS51388 | |
| Domain | Dynamin_GTPase_CS | 2.73e-05 | 6 | 210 | 3 | IPR019762 | |
| Domain | GED | 2.73e-05 | 6 | 210 | 3 | PF02212 | |
| Domain | GED | 2.73e-05 | 6 | 210 | 3 | IPR003130 | |
| Domain | A/G_cyclase_CS | 3.30e-05 | 17 | 210 | 4 | IPR018297 | |
| Domain | - | 4.20e-05 | 18 | 210 | 4 | 3.30.70.1230 | |
| Domain | Nucleotide_cyclase | 4.20e-05 | 18 | 210 | 4 | IPR029787 | |
| Domain | G_DYNAMIN_1 | 4.74e-05 | 7 | 210 | 3 | PS00410 | |
| Domain | DYNc | 4.74e-05 | 7 | 210 | 3 | SM00053 | |
| Domain | Guanylate_cyc | 5.27e-05 | 19 | 210 | 4 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 5.27e-05 | 19 | 210 | 4 | PS50125 | |
| Domain | A/G_cyclase | 5.27e-05 | 19 | 210 | 4 | IPR001054 | |
| Domain | GUANYLATE_CYCLASE_1 | 5.27e-05 | 19 | 210 | 4 | PS00452 | |
| Domain | CYCc | 5.27e-05 | 19 | 210 | 4 | SM00044 | |
| Domain | zf-C2H2_6 | ZBTB48 PRDM2 ZNF615 ZNF860 ZNF468 ZNF418 ZNF607 ZNF501 ZNF92 ZNF540 ZNF808 ZNF761 ZNF99 | 5.88e-05 | 314 | 210 | 13 | PF13912 |
| Domain | TPR_REGION | 1.07e-04 | 165 | 210 | 9 | PS50293 | |
| Domain | TPR | 1.07e-04 | 165 | 210 | 9 | PS50005 | |
| Domain | Pept_M12B_GON-ADAMTSs | 1.26e-04 | 2 | 210 | 2 | IPR012314 | |
| Domain | GON | 1.26e-04 | 2 | 210 | 2 | PS51046 | |
| Domain | GON | 1.26e-04 | 2 | 210 | 2 | PF08685 | |
| Domain | ARM-type_fold | DCAF1 USP9X USP9Y RYR3 ITPR1 ITPR2 PKP2 UNC79 FMNL1 DOCK8 HEATR1 FMNL3 PPP4R3B | 1.27e-04 | 339 | 210 | 13 | IPR016024 |
| Domain | TPR_repeat | 1.32e-04 | 133 | 210 | 8 | IPR019734 | |
| Domain | KRAB | ZNF550 ZNF615 ZNF860 ZNF468 ZNF418 ZNF607 ZNF510 ZNF28 ZNF92 ZNF540 ZNF808 ZNF761 ZNF99 | 2.17e-04 | 358 | 210 | 13 | PS50805 |
| Domain | KRAB | ZNF550 ZNF615 ZNF860 ZNF468 ZNF418 ZNF607 ZNF510 ZNF28 ZNF92 ZNF540 ZNF808 ZNF761 ZNF99 | 2.17e-04 | 358 | 210 | 13 | PF01352 |
| Domain | KRAB | ZNF550 ZNF615 ZNF860 ZNF468 ZNF418 ZNF607 ZNF510 ZNF28 ZNF92 ZNF540 ZNF808 ZNF761 ZNF99 | 2.91e-04 | 369 | 210 | 13 | SM00349 |
| Domain | KRAB | ZNF550 ZNF615 ZNF860 ZNF468 ZNF418 ZNF607 ZNF510 ZNF28 ZNF92 ZNF540 ZNF808 ZNF761 ZNF99 | 2.98e-04 | 370 | 210 | 13 | IPR001909 |
| Domain | TPR-contain_dom | 3.00e-04 | 150 | 210 | 8 | IPR013026 | |
| Domain | TPR_8 | 3.17e-04 | 53 | 210 | 5 | PF13181 | |
| Domain | DUF1126 | 3.75e-04 | 3 | 210 | 2 | IPR010554 | |
| Domain | DUF1126 | 3.75e-04 | 3 | 210 | 2 | PF06565 | |
| Domain | DM10 | 3.75e-04 | 3 | 210 | 2 | SM00676 | |
| Domain | DM10 | 3.75e-04 | 3 | 210 | 2 | PS51336 | |
| Domain | Uncharacterised_DM10 | 3.75e-04 | 3 | 210 | 2 | IPR006602 | |
| Domain | G_DYNAMIN_dom | 4.65e-04 | 14 | 210 | 3 | IPR030381 | |
| Domain | G_DYNAMIN_2 | 4.65e-04 | 14 | 210 | 3 | PS51718 | |
| Domain | TPR_1 | 5.34e-04 | 90 | 210 | 6 | IPR001440 | |
| Domain | TPR_1 | 5.34e-04 | 90 | 210 | 6 | PF00515 | |
| Domain | Dynamin_GTPase | 5.77e-04 | 15 | 210 | 3 | IPR001401 | |
| Domain | Dynamin_SF | 5.77e-04 | 15 | 210 | 3 | IPR022812 | |
| Domain | Dynamin_N | 5.77e-04 | 15 | 210 | 3 | PF00350 | |
| Domain | TPR | 6.45e-04 | 129 | 210 | 7 | SM00028 | |
| Domain | ALBUMIN | 7.44e-04 | 4 | 210 | 2 | SM00103 | |
| Domain | Serum_albumin_N | 7.44e-04 | 4 | 210 | 2 | IPR014760 | |
| Domain | KASH | 7.44e-04 | 4 | 210 | 2 | IPR012315 | |
| Domain | KASH | 7.44e-04 | 4 | 210 | 2 | PS51049 | |
| Domain | Serum_albumin_CS | 7.44e-04 | 4 | 210 | 2 | IPR020857 | |
| Domain | ALBUMIN_2 | 7.44e-04 | 4 | 210 | 2 | PS51438 | |
| Domain | KASH | 7.44e-04 | 4 | 210 | 2 | SM01249 | |
| Domain | KASH | 7.44e-04 | 4 | 210 | 2 | PF10541 | |
| Domain | ALBUMIN_1 | 7.44e-04 | 4 | 210 | 2 | PS00212 | |
| Domain | Serum_albumin | 7.44e-04 | 4 | 210 | 2 | PF00273 | |
| Domain | Serum_albumin-like | 1.23e-03 | 5 | 210 | 2 | IPR020858 | |
| Domain | - | 1.23e-03 | 5 | 210 | 2 | 1.10.1450.10 | |
| Domain | CD81_LEL | 1.23e-03 | 5 | 210 | 2 | IPR028977 | |
| Domain | TPR-like_helical_dom | 1.32e-03 | 233 | 210 | 9 | IPR011990 | |
| Domain | Adcy_conserved_dom | 1.83e-03 | 6 | 210 | 2 | IPR009398 | |
| Domain | E1_dh | 1.83e-03 | 6 | 210 | 2 | PF00676 | |
| Domain | Ca_hom_mod | 1.83e-03 | 6 | 210 | 2 | PF14798 | |
| Domain | DUF1053 | 1.83e-03 | 6 | 210 | 2 | PF06327 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 3.03e-06 | 10 | 158 | 4 | M47661 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 5.86e-06 | 41 | 158 | 6 | M512 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | MCF2L PREX1 FMNL1 DOCK8 ARHGAP10 CDC42BPB FMNL3 ARHGEF26 ARHGAP45 SPATA13 | 9.59e-06 | 155 | 158 | 10 | M41808 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 1.36e-05 | 5 | 158 | 3 | M49000 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 2.70e-05 | 6 | 158 | 3 | M47960 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 2.99e-05 | 54 | 158 | 6 | M26911 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 4.09e-05 | 147 | 158 | 9 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 5.05e-05 | 151 | 158 | 9 | M39329 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 5.16e-05 | 19 | 158 | 4 | M47760 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 5.89e-05 | 154 | 158 | 9 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 6.51e-05 | 156 | 158 | 9 | M39475 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 6.67e-05 | 90 | 158 | 7 | M6467 | |
| Pathway | KEGG_GAP_JUNCTION | 6.67e-05 | 90 | 158 | 7 | M4013 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 8.80e-05 | 94 | 158 | 7 | MM15598 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 1.01e-04 | 42 | 158 | 5 | M791 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.10e-04 | 9 | 158 | 3 | M47852 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 1.56e-04 | 10 | 158 | 3 | M19522 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 1.56e-04 | 10 | 158 | 3 | MM14668 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.57e-04 | 175 | 158 | 9 | MM15599 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 1.57e-04 | 46 | 158 | 5 | M39828 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.60e-04 | 25 | 158 | 4 | MM14511 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.13e-04 | 11 | 158 | 3 | M49033 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 2.13e-04 | 11 | 158 | 3 | M27466 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 2.18e-04 | 27 | 158 | 4 | M12123 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 2.29e-04 | 184 | 158 | 9 | M41809 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 2.78e-04 | 113 | 158 | 7 | M16817 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 3.10e-04 | 115 | 158 | 7 | M9387 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 3.64e-04 | 13 | 158 | 3 | M47656 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.64e-04 | 13 | 158 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 3.64e-04 | 13 | 158 | 3 | M47751 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 3.64e-04 | 13 | 158 | 3 | MM14553 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | USP9X NHS MCF2L PREX1 FMNL1 KALRN DOCK8 ARHGAP10 CDC42BPB FMNL3 MACO1 ARHGEF26 ARHGAP45 SPATA13 | 4.23e-04 | 439 | 158 | 14 | MM15595 |
| Pathway | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | 4.59e-04 | 14 | 158 | 3 | M10122 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 4.59e-04 | 14 | 158 | 3 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 4.59e-04 | 14 | 158 | 3 | M750 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | USP9X NHS MCF2L PREX1 FMNL1 KALRN DOCK8 ARHGAP10 CDC42BPB FMNL3 MACO1 ARHGEF26 ARHGAP45 SPATA13 | 5.41e-04 | 450 | 158 | 14 | M27078 |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 5.69e-04 | 15 | 158 | 3 | M47794 | |
| Pathway | PID_LPA4_PATHWAY | 5.69e-04 | 15 | 158 | 3 | M56 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 5.69e-04 | 15 | 158 | 3 | M47504 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 5.96e-04 | 61 | 158 | 5 | MM15071 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 6.77e-04 | 36 | 158 | 4 | M1315 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 6.89e-04 | 95 | 158 | 6 | M29842 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 6.95e-04 | 16 | 158 | 3 | M47645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 6.95e-04 | 16 | 158 | 3 | M47650 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 6.95e-04 | 16 | 158 | 3 | MM14492 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 6.95e-04 | 16 | 158 | 3 | M26945 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 6.95e-04 | 16 | 158 | 3 | M39849 | |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 7.28e-04 | 96 | 158 | 6 | M16121 | |
| Pathway | PID_RAC1_REG_PATHWAY | 8.33e-04 | 38 | 158 | 4 | M241 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 8.37e-04 | 17 | 158 | 3 | M26995 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 8.37e-04 | 17 | 158 | 3 | M47544 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 9.51e-04 | 101 | 158 | 6 | M1979 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.09e-03 | 142 | 158 | 7 | MM15576 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 1.17e-03 | 19 | 158 | 3 | M27423 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.17e-03 | 19 | 158 | 3 | M47733 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.27e-03 | 72 | 158 | 5 | MM14631 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | REPS1 SPTBN2 HSPH1 RABGAP1 COG3 TBC1D8B COLEC12 DNM1 DNM2 CALR CAPZA2 AP1M2 DENND3 ARRB2 NAPB DENND2C PAFAH1B2 DNM3 | 1.28e-03 | 725 | 158 | 18 | M27507 |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.35e-03 | 108 | 158 | 6 | M17034 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 1.37e-03 | 20 | 158 | 3 | M47688 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.37e-03 | 20 | 158 | 3 | M759 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 1.44e-03 | 74 | 158 | 5 | MM15962 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.44e-03 | 149 | 158 | 7 | M41805 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 1.58e-03 | 21 | 158 | 3 | M47689 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 1.62e-03 | 76 | 158 | 5 | M9052 | |
| Pathway | SIG_BCR_SIGNALING_PATHWAY | 1.72e-03 | 46 | 158 | 4 | M8626 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.81e-03 | 78 | 158 | 5 | M1921 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_F_RECEPTORS | 1.82e-03 | 6 | 158 | 2 | M27222 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.82e-03 | 22 | 158 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.82e-03 | 22 | 158 | 3 | M47675 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 1.94e-03 | 116 | 158 | 6 | MM14855 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.08e-03 | 23 | 158 | 3 | M47676 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 2.35e-03 | 24 | 158 | 3 | M47520 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | REPS1 SPTBN2 RABGAP1 COG3 TBC1D8B DNM1 DNM2 CALR CAPZA2 AP1M2 DENND3 ARRB2 NAPB DENND2C PAFAH1B2 DNM3 | 2.41e-03 | 645 | 158 | 16 | MM15232 |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 2.71e-03 | 52 | 158 | 4 | MM14743 | |
| Pubmed | REPS1 USP9X CORO1C SPTBN2 HSPH1 MCF2L2 POGZ USP9Y MTMR10 RYR3 ADAMTS9 GEMIN8 MIGA1 DNM1 PREX1 MTUS2 DNM2 GLIPR1 NRBP1 KALRN SYNE1 CAPZA2 APBA1 BTBD2 CDC42BPB PPP4R3B RPRD1A NAPB CTR9 ZNF92 DNM3 SLX4 PCNT | 5.11e-12 | 1285 | 216 | 33 | 35914814 | |
| Pubmed | URI1 USP9X CORO1C SPTBN2 BMS1 RB1CC1 BIRC6 MTMR10 ADCY9 ITPR1 ITPR2 ITPR3 SYNE2 NHS DEK RANBP2 ARHGAP10 CALR MINK1 PTPRU CDC42BPB PPP4R3B P4HA1 CTR9 MACO1 PCNT | 2.37e-09 | 1049 | 216 | 26 | 27880917 | |
| Pubmed | TACO1 ZNF326 REPS1 ERP44 PDHA1 MCF2L2 DUS3L ASAP2 PKP2 PPIP5K2 MCF2L DEK PREX1 DNM2 DOCK8 ARHGAP10 CALR CAPZA2 HEATR1 RPRD1A MACO1 DNM3 ARHGEF26 SPATA13 | 3.52e-09 | 916 | 216 | 24 | 32203420 | |
| Pubmed | SPTBN2 HSPH1 ATP10B ADCY6 SYNE2 ZBTB21 XRN1 PIP4K2B DLEC1 PPIP5K2 MCF2L PREX1 RANBP2 MACC1 SYNE1 CAPZA2 DNAH2 SPG11 HEATR1 OGDH GUCY1A2 SETD5 CTR9 CEP295 POTEJ SPAG17 CDC27 DNAJC3 SPATA13 PCNT | 7.27e-09 | 1442 | 216 | 30 | 35575683 | |
| Pubmed | USP9X CORO1C SPTBN2 EPM2AIP1 SYNE2 ZBTB21 DNM1 UNC79 KCNT1 DNM2 RANBP2 KALRN SYNE1 MINK1 CAPZA2 DGKZ CDC42BPB CCDC88C DNM3 FSCN1 ARHGEF26 SPATA13 CDK5 PCNT | 9.22e-09 | 963 | 216 | 24 | 28671696 | |
| Pubmed | DCAF1 TACO1 PDHA1 SPTBN2 HSPH1 BMS1 RB1CC1 ADCY9 ITPR1 ITPR2 ITPR3 GEMIN8 SYNE2 DEK NRBP1 CALR SYNE1 MINK1 SPG11 HEATR1 OGDH CDC42BPB P4HA1 CTR9 MACO1 LSS FSCN1 DNAJC3 PCNT ZC3HAV1 | 1.45e-08 | 1487 | 216 | 30 | 33957083 | |
| Pubmed | 2.15e-08 | 6 | 216 | 4 | 23463619 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 2.15e-08 | 6 | 216 | 4 | 25966694 | |
| Pubmed | 2.15e-08 | 6 | 216 | 4 | 20519450 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 2.15e-08 | 6 | 216 | 4 | 16844763 | |
| Pubmed | 4.99e-08 | 7 | 216 | 4 | 11860456 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DCAF1 ZNF326 URI1 ERP44 BMS1 MTMR10 POF1B ITPR3 FBXO22 SNX8 XRN1 UMPS NRBP1 RANBP2 ARHGAP10 CALR DGKZ HEATR1 PTPRU CTR9 MACO1 DNAJC3 ZC3HAV1 | 5.10e-08 | 974 | 216 | 23 | 28675297 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DCAF1 HAUS6 URI1 BBS4 ADCY6 CNOT6 ASAP2 EFHC1 ZBTB21 PPIP5K2 CCDC93 DNM2 CUL4B ARHGAP10 CALR CAPZA2 HEATR1 EFHC2 CNOT6L RPRD1A SETD5 CTR9 PAFAH1B2 TTC21B CDC27 CDK5 ZC3HAV1 | 6.32e-08 | 1321 | 216 | 27 | 27173435 |
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 10874040 | ||
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 20395455 | ||
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 17437169 | ||
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 18547250 | ||
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 36350267 | ||
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 11413485 | ||
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 26009177 | ||
| Pubmed | Receptor-activated single channels in intact human platelets. | 2.36e-07 | 3 | 216 | 3 | 1693919 | |
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 23955339 | ||
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 12511974 | ||
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 31979185 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 2.36e-07 | 3 | 216 | 3 | 24904548 | |
| Pubmed | Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes. | 2.36e-07 | 3 | 216 | 3 | 9858485 | |
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 9808793 | ||
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 12383797 | ||
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 18194433 | ||
| Pubmed | IP3 receptors regulate vascular smooth muscle contractility and hypertension. | 2.36e-07 | 3 | 216 | 3 | 27777977 | |
| Pubmed | Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line. | 2.36e-07 | 3 | 216 | 3 | 17581770 | |
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 24273169 | ||
| Pubmed | Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction. | 2.36e-07 | 3 | 216 | 3 | 18241669 | |
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 19068129 | ||
| Pubmed | Developmental expression of the dynamin family of mechanoenzymes in the mouse epididymis. | 2.36e-07 | 3 | 216 | 3 | 28395327 | |
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 17327232 | ||
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 16014380 | ||
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 12517701 | ||
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 17890015 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. | 2.36e-07 | 3 | 216 | 3 | 23983250 | |
| Pubmed | Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors. | 2.36e-07 | 3 | 216 | 3 | 24046449 | |
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 20427533 | ||
| Pubmed | HAUS6 ERP44 PDHA1 USP9X HSPH1 BIRC6 FBXO22 XRN1 UMPS DNM2 RANBP2 CALR CAPZA2 CDC27 CDK5 ZC3HAV1 | 2.77e-07 | 534 | 216 | 16 | 35032548 | |
| Pubmed | HAUS6 ERP44 SPTBN2 HSPH1 BIRC6 ASAP2 SAMD9L ADAMTS9 DSTYK PREX1 CDC42BPB DENND3 CCDC88C TTC21B SLX4 | 5.44e-07 | 493 | 216 | 15 | 15368895 | |
| Pubmed | DCAF1 ZNF326 USP9X SPTBN2 HSPH1 ITPR3 SERPINB9 UMPS DNM2 SENP5 CUL4B OGDH LSS FSCN1 CDC27 CDK5 ZC3HAV1 | 5.48e-07 | 634 | 216 | 17 | 34591612 | |
| Pubmed | PDHA1 USP9X SPTBN2 BMS1 POGZ BIRC6 ITPR3 SYNE2 XRN1 DNM2 CUL4B RANBP2 CALR HEATR1 FSCN1 PCNT ZC3HAV1 | 8.21e-07 | 653 | 216 | 17 | 22586326 | |
| Pubmed | 8.59e-07 | 52 | 216 | 6 | 9455477 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 25215520 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 11163362 | ||
| Pubmed | Overlapping role of dynamin isoforms in synaptic vesicle endocytosis. | 9.41e-07 | 4 | 216 | 3 | 21689597 | |
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 22846998 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptor interacts with the SNARE domain of syntaxin 1B. | 9.41e-07 | 4 | 216 | 3 | 21424589 | |
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 28615414 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 10828023 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 28419336 | ||
| Pubmed | IP3R-mediated Ca2+ signaling controls B cell proliferation through metabolic reprogramming. | 9.41e-07 | 4 | 216 | 3 | 35494252 | |
| Pubmed | BIRC6 ADCY6 ADCY9 SYNE2 PREX1 CUL4B SYNE1 CDC42BPB DNM3 PCNT | 1.63e-06 | 225 | 216 | 10 | 12168954 | |
| Pubmed | POF1B ITPR3 SNX8 PKP2 PPIP5K2 CALR DGKZ OGDH FMNL3 ARHGAP45 ZC3HAV1 | 2.14e-06 | 288 | 216 | 11 | 38496616 | |
| Pubmed | 2.34e-06 | 5 | 216 | 3 | 9722593 | ||
| Pubmed | InsP₃receptors and Orai channels in pancreatic acinar cells: co-localization and its consequences. | 2.34e-06 | 5 | 216 | 3 | 21568942 | |
| Pubmed | HAUS6 ERP44 RABGAP1 POGZ RB1CC1 BIRC6 PRDM2 SALL1 ZBTB21 XRN1 RANBP2 ARRB2 PCNT | 2.49e-06 | 418 | 216 | 13 | 34709266 | |
| Pubmed | DCAF1 RB1CC1 EPM2AIP1 ITPR3 PPIP5K2 DNM2 OGDH CDC42BPB LIMD2 PAFAH1B2 FSCN1 PCNT | 3.01e-06 | 360 | 216 | 12 | 33111431 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | USP9X CORO1C SPTBN2 HSPH1 GC USP9Y RYR3 IFIH1 FBXO22 SPG11 XIRP2 P4HA1 ZNF540 ZNF99 | 3.21e-06 | 497 | 216 | 14 | 36774506 |
| Pubmed | PDHA1 USP9X CORO1C SPTBN2 HSPH1 ITPR2 AJM1 XRN1 DNM1 MTUS2 DNM2 KALRN DOCK8 SYNE1 MINK1 CAPZA2 DGKZ OGDH CDC42BPB GUCY1A2 NAPB PAFAH1B2 FSCN1 CDK5 DNAH11 | 3.44e-06 | 1431 | 216 | 25 | 37142655 | |
| Pubmed | ZNF326 REPS1 SPTBN2 HSPH1 BMS1 COG3 ITPR1 ITPR2 ITPR3 SYNE2 UMPS DEK CCDC93 RANBP2 CALR CAPZA2 HEATR1 OGDH GFM2 POLR3A CNOT6L CD9 MACO1 CDK5 ZC3HAV1 | 3.84e-06 | 1440 | 216 | 25 | 30833792 | |
| Pubmed | USP9X GALNT7 BIRC6 ITPR1 ITPR2 ITPR3 CNOT6 SERPINB9 XRN1 FMNL1 GLIPR1 RANBP2 DOCK8 CALR HEATR1 POLR3A P4HA1 CD81 LSS ARHGAP45 DNAJC3 PCNT | 4.27e-06 | 1168 | 216 | 22 | 19946888 | |
| Pubmed | ERP44 HSPH1 PEX1 BBS4 GALNT7 DUS3L PRDM2 ITPR1 DNM2 CAPZA2 DGKZ SALL4 HEATR1 CNOT6L SETD5 CTR9 CEP295 TNFAIP3 CDC27 SLX4 PCNT | 4.65e-06 | 1084 | 216 | 21 | 11544199 | |
| Pubmed | 4.66e-06 | 6 | 216 | 3 | 23640057 | ||
| Pubmed | 4.66e-06 | 6 | 216 | 3 | 27251629 | ||
| Pubmed | Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release. | 4.66e-06 | 6 | 216 | 3 | 21762810 | |
| Pubmed | 4.66e-06 | 6 | 216 | 3 | 18602423 | ||
| Pubmed | URI1 ERP44 PDHA1 USP9X POLR2M USP9Y ZZEF1 CNOT6 PIP4K2B CALR OGDH CTR9 CDC27 CDK5 | 7.11e-06 | 533 | 216 | 14 | 25544563 | |
| Pubmed | Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. | 8.12e-06 | 7 | 216 | 3 | 22495310 | |
| Pubmed | 8.12e-06 | 7 | 216 | 3 | 15252009 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | PDHA1 HSPH1 ADCY6 ITPR1 ASAP2 ADAMTS20 DNM1 DNM2 DOCK8 MINK1 CAPZA2 OGDH CD9 NAPB CDK5 | 9.05e-06 | 621 | 216 | 15 | 22794259 |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 1.10e-05 | 168 | 216 | 8 | 30631154 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | DCAF1 HAUS6 ZNF326 CORO1C POGZ POF1B ITPR1 CNOT6 PER2 NAA16 CUL4B RANBP2 CALR SYNE1 ARRB2 CNOT6L PAFAH1B2 FSCN1 CDC27 SLX4 CDK5 | 1.21e-05 | 1155 | 216 | 21 | 20360068 |
| Pubmed | 1.29e-05 | 8 | 216 | 3 | 37871017 | ||
| Pubmed | 1.29e-05 | 8 | 216 | 3 | 15834155 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.29e-05 | 8 | 216 | 3 | 19033399 | |
| Pubmed | 1.29e-05 | 8 | 216 | 3 | 24282027 | ||
| Pubmed | CAPN9 KLHL28 GCNT3 USP9X CORO1C DNM1 DNM2 CUL4B DNAH2 PTPRU CDC42BPB POLR3A SETD5 KLHL12 TUBE1 DNAH11 | 1.51e-05 | 730 | 216 | 16 | 34857952 | |
| Pubmed | PEX1 ZZEF1 ADCY6 ITPR1 DSTYK XRN1 PPIP5K2 DNM1 PZP DNM2 MINK1 DENND3 POLR3A CTR9 ZC3HAV1 | 1.54e-05 | 650 | 216 | 15 | 38777146 | |
| Pubmed | REPS1 MYOM1 BIRC6 ADAMTS9 SYNE2 TRIM38 DNM2 RANBP2 KALRN SYNE1 CDC42BPB XIRP2 P4HA1 | 1.58e-05 | 497 | 216 | 13 | 23414517 | |
| Pubmed | 1.67e-05 | 233 | 216 | 9 | 37704626 | ||
| Pubmed | 1.78e-05 | 87 | 216 | 6 | 33711283 | ||
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 1.79e-05 | 235 | 216 | 9 | 28378594 | |
| Pubmed | 1.93e-05 | 9 | 216 | 3 | 25737585 | ||
| Pubmed | 1.93e-05 | 9 | 216 | 3 | 23170932 | ||
| Pubmed | 1.93e-05 | 9 | 216 | 3 | 12503609 | ||
| Pubmed | Role of the calcium modulated cyclases in the development of the retinal projections. | 1.93e-05 | 9 | 216 | 3 | 17229090 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | USP9X ITPR1 ITPR2 ITPR3 PKP2 RANBP2 PPP4R3B RPRD1A CTR9 CDC27 SLX4 ZC3HAV1 | 2.25e-05 | 440 | 216 | 12 | 34244565 |
| Pubmed | 2.27e-05 | 27 | 216 | 4 | 19723784 | ||
| Pubmed | Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. | 2.75e-05 | 10 | 216 | 3 | 11884542 | |
| Pubmed | 2.75e-05 | 10 | 216 | 3 | 23746204 | ||
| Pubmed | 2.75e-05 | 10 | 216 | 3 | 10398046 | ||
| Pubmed | Purification and characterization of a soluble form of mammalian adenylyl cyclase. | 2.75e-05 | 10 | 216 | 3 | 8663304 | |
| Pubmed | 2.75e-05 | 10 | 216 | 3 | 16615126 | ||
| Pubmed | 3.00e-05 | 251 | 216 | 9 | 27507650 | ||
| Pubmed | TRIM35 BMS1 POGZ ZZEF1 ADCY9 CNOT6 AP5Z1 ZBTB21 PPIP5K2 KCNT1 SPG11 FMNL3 PPP4R3B | 3.03e-05 | 529 | 216 | 13 | 14621295 | |
| Cytoband | 7q21.2 | 4.42e-05 | 15 | 215 | 3 | 7q21.2 | |
| Cytoband | 2q24.3 | 5.42e-05 | 16 | 215 | 3 | 2q24.3 | |
| Cytoband | 3p21.3 | 1.74e-04 | 59 | 215 | 4 | 3p21.3 | |
| Cytoband | 19q13.41 | 5.09e-04 | 78 | 215 | 4 | 19q13.41 | |
| Cytoband | 12p11 | 7.69e-04 | 9 | 215 | 2 | 12p11 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF326 ZBTB48 KLF14 SALL1 ZNF550 ZBTB21 ZNF615 ZNF860 ZNF468 ZNF418 ZNF607 SALL4 ZNF510 ZNF501 ZNF28 ZNF92 ZNF540 ZFHX2 ZNF808 ZNF761 ZNF99 ZNF415 | 6.43e-08 | 718 | 145 | 22 | 28 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | SPTBN2 ASAP2 MCF2L DNM1 PREX1 DNM2 RASGRF1 ASAP3 PLEKHD1 DNM3 ARHGEF26 SPATA13 | 1.04e-07 | 206 | 145 | 12 | 682 |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 5.05e-07 | 3 | 145 | 3 | 297 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.68e-07 | 66 | 145 | 7 | 722 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.93e-05 | 115 | 145 | 7 | 769 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 5.82e-05 | 10 | 145 | 3 | 53 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 3.79e-04 | 4 | 145 | 2 | 1252 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 7.40e-04 | 51 | 145 | 4 | 870 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 7.42e-04 | 134 | 145 | 6 | 861 | |
| GeneFamily | EF-hand domain containing | 1.96e-03 | 219 | 145 | 7 | 863 | |
| GeneFamily | CCR4-NOT transcription complex | 3.35e-03 | 11 | 145 | 2 | 1023 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | HAUS6 URI1 KLHL28 USP9X RB1CC1 BIRC6 PRDM2 ITPR1 ITPR2 SAMD9L SERPINB9 DSTYK XRN1 DEK TRIM38 PREX1 FMNL1 GLIPR1 RANBP2 DOCK8 SYNE1 SPG11 FMNL3 LIMD2 CCDC88C PPP4R3B ARRB2 CNOT6L SETD5 CD81 TNFAIP3 ARHGAP45 SPATA13 ZC3HAV1 | 6.25e-08 | 1492 | 215 | 34 | M40023 |
| Coexpression | GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP | URI1 IFIH1 SAMD9L SERPINB9 TOR3A DEK PARP11 CALHM6 CNOT6L LSS CEP295 SPATA13 | 1.08e-07 | 200 | 215 | 12 | M8559 |
| Coexpression | DESCARTES_FETAL_SPLEEN_MEGAKARYOCYTES | 4.70e-06 | 114 | 215 | 8 | M40293 | |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 2.25e-05 | 184 | 215 | 9 | M19988 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | HAUS6 USP9X HSPH1 RB1CC1 ITPR1 ITPR2 IFIH1 SYNE2 PPIP5K2 DEK CUL4B GLIPR1 ARHGAP10 SPG11 DNAJC3 ZNF654 PUS7L | 3.23e-05 | 656 | 215 | 17 | M18979 |
| Coexpression | GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_DN | 4.33e-05 | 200 | 215 | 9 | M6039 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN | HSPH1 ADCY5 GLIPR1 TMEM31 PPP4R3B CD81 TNFAIP3 ARHGAP45 SPATA13 | 4.33e-05 | 200 | 215 | 9 | M6529 |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 4.33e-05 | 200 | 215 | 9 | M9188 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | KLHL28 GCNT3 USP9X TRIM35 PEX1 ATP10B RABGAP1 BIRC6 ITPR1 SAMD9L SALL1 AFP PKP2 ADAMTS20 TOR3A GULP1 CUL4B DOCK8 AP1M2 NAPB TUBE1 DNAJC3 ZNF654 SPATA13 | 6.57e-07 | 774 | 208 | 24 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | KLHL28 USP9X TRIM35 RABGAP1 BIRC6 MIGA1 GULP1 SENP5 SALL4 NAPB SETD5 FSCN1 TUBE1 DNAJC3 | 2.84e-05 | 385 | 208 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_1000 | GCNT3 USP9X TRIM35 SPTBN2 ATP10B RABGAP1 BIRC6 POF1B ITPR2 ITPR3 SAMD9L AFP PKP2 MIGA1 NRBP1 DOCK8 AP1M2 CD9 NAPB RASSF9 DNAJC3 | 3.22e-05 | 786 | 208 | 21 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | KLHL28 USP9X TRIM35 RABGAP1 LDAH POF1B ADCY5 RYR3 SALL1 MIGA1 DNM2 GULP1 MACC1 KALRN NAPB SETD5 CTR9 ENTPD3 RASSF9 FSCN1 CDC27 | 4.63e-05 | 806 | 208 | 21 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | KLHL28 USP9X TRIM35 RABGAP1 BIRC6 ITPR1 ADAMTS20 GULP1 CUL4B DOCK8 TUBE1 DNAJC3 ZNF654 | 8.91e-05 | 375 | 208 | 13 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | DCAF1 HAUS6 ZNF326 URI1 USP9X HSPH1 RB1CC1 MTMR10 FREM1 IGSF10 SYNE2 NHS PPIP5K2 DNM1 DEK PREX1 FMNL1 NAA16 CUL4B PPP4R3B SETD5 CTR9 CEP295 ZNF761 TMEM39A CDC27 ZNF654 | 9.81e-05 | 1252 | 208 | 27 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | MYOM1 ADCY6 FREM1 IGSF10 ASAP2 PKP2 KALRN EFHC2 XIRP2 DENND2C DNM3 | 2.62e-09 | 191 | 216 | 11 | 7edc22e7e70697fb22690699efb352577162709b |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FREM1 RYR3 SYCP2 ADAMTS20 UNC79 KALRN SALL4 XIRP2 SPAG17 DNAH11 | 2.44e-08 | 184 | 216 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FREM1 RYR3 SYCP2 ADAMTS20 UNC79 KALRN SALL4 XIRP2 SPAG17 DNAH11 | 2.44e-08 | 184 | 216 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FREM1 RYR3 SYCP2 ADAMTS20 UNC79 KALRN SALL4 XIRP2 SPAG17 DNAH11 | 2.44e-08 | 184 | 216 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | USP9X HSPH1 RB1CC1 BIRC6 PRDM2 ITPR1 SYNE2 RANBP2 TNFAIP3 ZC3HAV1 | 2.99e-08 | 188 | 216 | 10 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | MYOM1 ADCY6 IGSF10 ASAP2 PKP2 KALRN EFHC2 XIRP2 DENND2C DNM3 | 3.65e-08 | 192 | 216 | 10 | b877d14be9d04ab0010e340909e3a23de92613db |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SAMD9L SYNE2 XRN1 PZP CALR SYNE1 CCDC88C CNOT6L CD81 TNFAIP3 | 5.36e-08 | 200 | 216 | 10 | 109f673a4967ffa52270a0b4f818b3461288db44 |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.89e-07 | 183 | 216 | 9 | 9c66a40c355387f805dbdca4162dd05af5c1d8d4 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.03e-07 | 184 | 216 | 9 | ba65e3972b2b8d825a2c1a9d03d092cc1afad073 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.47e-07 | 187 | 216 | 9 | 34cad5ac8602fe88ca3d421257190c9a388d4cb0 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.97e-07 | 190 | 216 | 9 | 64060e4b56ac9989e659c2d5d2a6b6edeba4d8d4 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-MK-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.53e-07 | 193 | 216 | 9 | 3d4411b3c1cb160dec5db29f0c126d8827dfe185 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.53e-07 | 193 | 216 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | IPF-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 4.53e-07 | 193 | 216 | 9 | 03a43b6d235fd47488a6a61efc311a34b232c0f4 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.73e-07 | 194 | 216 | 9 | 216cba1a04b1a24b080322bc950e7fa2dade5ff1 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-early_MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.94e-07 | 195 | 216 | 9 | 9b4f217325afb2efb9c65f298ac87649cb1e1af9 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-MK-early_MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.16e-07 | 196 | 216 | 9 | fc541e328aed28e84d5b3835169c60da0d64cddc | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | HSPH1 SYNE2 XRN1 SYNE1 CNOT6L ZNF540 TMEM39A TNFAIP3 ZC3HAV1 | 5.16e-07 | 196 | 216 | 9 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.16e-07 | 196 | 216 | 9 | 66ba31b74953726e9c314f6d8fe3f75d3762e23a | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.10e-07 | 200 | 216 | 9 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-06 | 178 | 216 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-06 | 179 | 216 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-06 | 180 | 216 | 8 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.23e-06 | 183 | 216 | 8 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.23e-06 | 183 | 216 | 8 | 6cbc88c27dc957d182526e84824f70c8e860bf74 | |
| ToppCell | megakaryocytic|World / Lineage and Cell class | 3.36e-06 | 184 | 216 | 8 | b1c630ca2189d9d49402a5621b57618976fbea5c | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.78e-06 | 187 | 216 | 8 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.78e-06 | 187 | 216 | 8 | 72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.94e-06 | 188 | 216 | 8 | c00ba0abd0c7bb2c8f9166a2ac6220aae4f4d857 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|COPD / Disease state, Lineage and Cell class | 4.26e-06 | 190 | 216 | 8 | 006e31606d637033bc81333816ee332773d36b08 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.42e-06 | 191 | 216 | 8 | 40813c397f533c2f4a6359a77757f736b6d9e07d | |
| ToppCell | Ciliated-cil-3|World / Class top | 4.60e-06 | 192 | 216 | 8 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells-Megakaryocyte|World / Lineage, cell class and subclass | 4.78e-06 | 193 | 216 | 8 | 352cd442b6e62f09b6d22a139774067873644594 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.96e-06 | 194 | 216 | 8 | 245a3eb6db9c862b73ad34a8cd2898a3688c16f6 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.15e-06 | 195 | 216 | 8 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.15e-06 | 195 | 216 | 8 | 1e794839a251fbc6e6ce419b4c457ead35a04735 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.55e-06 | 197 | 216 | 8 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.76e-06 | 198 | 216 | 8 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | Sigmoid-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 5.76e-06 | 198 | 216 | 8 | 305d7ae9b070ac7211638a5282374c02bf13af40 | |
| ToppCell | CD8+_Memory_T_cell-CV|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 5.76e-06 | 198 | 216 | 8 | 3d1749f5106f0912f4a74615863853949f52c73d | |
| ToppCell | CV|World / Virus stimulation, Condition and Cluster | 5.76e-06 | 198 | 216 | 8 | 6a28193af35abec5c029129930c2ca6febaafde2 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.98e-06 | 199 | 216 | 8 | 5ceeed92f831d068ff4bb3994f420002338330e7 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.21e-06 | 200 | 216 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.21e-06 | 200 | 216 | 8 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | 390C-Myeloid-Dendritic|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.21e-06 | 200 | 216 | 8 | 3935b6ff3ae32d170a268538c756ee34ed2308d4 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.21e-06 | 200 | 216 | 8 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.13e-05 | 156 | 216 | 7 | c380142e49b1e4ecacbf37587aafa57f8562b6ad | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.28e-05 | 159 | 216 | 7 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.83e-05 | 168 | 216 | 7 | 2d056cfbb470a088a0682576753535fb4528d48f | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.83e-05 | 168 | 216 | 7 | 2f69e248c6fab1421c0081e01e1920e6ffcde344 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Megakaryocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.90e-05 | 169 | 216 | 7 | d571e84e01e3316748d4407ed98881b17484e035 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.90e-05 | 169 | 216 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.05e-05 | 171 | 216 | 7 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | Dendritic_Cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.56e-05 | 177 | 216 | 7 | d2cd081bdda0eba9f6f6473c4d3939e4bee3440e | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.75e-05 | 179 | 216 | 7 | 898425fa81526a2e00fca7a25085229ff1f31069 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.75e-05 | 179 | 216 | 7 | 2fca4117c58824562ec80c7713fe15689a28efb3 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK-early_MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.75e-05 | 179 | 216 | 7 | d5b9c610c1519804b1753fed1b505293ea590867 | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)-(4)_1wkpi|(01)_Cycling_Basal_(homeostasis) / shred by cell type and Timepoint | 2.90e-05 | 122 | 216 | 6 | b2a070939c0660c82a1130ef423fd627e9e087ab | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-05 | 181 | 216 | 7 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.96e-05 | 181 | 216 | 7 | 5cecbafc29cc95896e6ccb2c74d9237b9aaece69 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Platelet|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.96e-05 | 181 | 216 | 7 | 724efbc200e8388829bc7d81830c2689a95fa838 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-05 | 181 | 216 | 7 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 182 | 216 | 7 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 3.17e-05 | 183 | 216 | 7 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.28e-05 | 184 | 216 | 7 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.40e-05 | 185 | 216 | 7 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.40e-05 | 185 | 216 | 7 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.48e-05 | 126 | 216 | 6 | cde3b0fbdc324120e45e295eb171ee550653de47 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.52e-05 | 186 | 216 | 7 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | COVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters | 3.52e-05 | 186 | 216 | 7 | 5954a1e3ffafb33f2a9bc87af3343f304fda4c92 | |
| ToppCell | Healthy/Control-CD4+_CTL|World / Disease group and Cell class | 3.64e-05 | 187 | 216 | 7 | d54d3214d77a9469e94a16c00a80626fd4953e2b | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.64e-05 | 127 | 216 | 6 | 9bc55cb9f4bddb274930784d12a83b9dceb35cb7 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8-Trm/em_CD8|blood / Manually curated celltypes from each tissue | 3.76e-05 | 188 | 216 | 7 | 21730497f95dc271e4cdfaaf1da8b9ac6eec2ded | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-05 | 188 | 216 | 7 | 1efbc99bcd6542e5d9fa91edb7c4295167914786 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.76e-05 | 188 | 216 | 7 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 3.76e-05 | 188 | 216 | 7 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.89e-05 | 189 | 216 | 7 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.89e-05 | 189 | 216 | 7 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.89e-05 | 189 | 216 | 7 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | IPF-Myeloid-Macrophage_Alveolar|IPF / Disease state, Lineage and Cell class | 4.03e-05 | 190 | 216 | 7 | e539ebc0f4c5ee5dba86c614387be7d91338ad47 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 4.03e-05 | 190 | 216 | 7 | 9fc763d65470ba8858b973689c4d4358faab7dd3 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.03e-05 | 190 | 216 | 7 | ad297172a74a80ed5c10f921e15efd1da0fd2d6b | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.03e-05 | 190 | 216 | 7 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.03e-05 | 190 | 216 | 7 | b4088128f5acf53f43244c9af9fe44e033f1a57a | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 4.03e-05 | 190 | 216 | 7 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.03e-05 | 190 | 216 | 7 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | Control-Classical_Monocyte-|Classical_Monocyte / Disease condition and Cell class | 4.15e-05 | 130 | 216 | 6 | 4433b40b099845f113993b6ecf85ec594b4b9219 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK-early_MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.16e-05 | 191 | 216 | 7 | 3839bf57419d3ec3d4464277bb33301d2b7d701f | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD8-Tem/emra_CD8|bone_marrow / Manually curated celltypes from each tissue | 4.16e-05 | 191 | 216 | 7 | db7b8f8826bf19d6eeee14319570a9e6e99ab2cb | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.30e-05 | 192 | 216 | 7 | 445985fe1bcd33e4f0a1704b27988fbfc9334538 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.45e-05 | 193 | 216 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Dendritic_Cells|World / lung cells shred on cell class, cell subclass, sample id | 4.45e-05 | 193 | 216 | 7 | 7792eb6e247af2d7a8f80476f37dcd880922d625 | |
| ToppCell | control-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.59e-05 | 194 | 216 | 7 | 267e213e8efe53aadfe553a2ca010a0e3b4b8939 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.59e-05 | 194 | 216 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.59e-05 | 194 | 216 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | HSPCs-Mk_prog.|HSPCs / Lineage and Cell class | 4.59e-05 | 194 | 216 | 7 | 5c05d508f5c29e6efe87506bf59e3b0fe5922f65 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 4.75e-05 | 195 | 216 | 7 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | CV-Severe-6|CV / Virus stimulation, Condition and Cluster | 4.75e-05 | 195 | 216 | 7 | 69095c6ce2a7e763afa543c10d5710e0c3dda769 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.75e-05 | 195 | 216 | 7 | b6bf75669f267ecdc96818c7022db852e37a9fe1 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.75e-05 | 195 | 216 | 7 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| Drug | Isoniazid [54-85-3]; Down 200; 29.2uM; PC3; HT_HG-U133A | BBS4 ADCY6 ITPR1 ITPR3 AP5Z1 CUL4B ARHGAP10 SYNE1 ASAP3 ARRB2 PAFAH1B2 ENTPD3 | 4.75e-07 | 199 | 216 | 12 | 2083_DN |
| Drug | etorphine | 1.41e-06 | 59 | 216 | 7 | CID000026721 | |
| Drug | Thiostrepton [1393-48-2]; Up 200; 2.4uM; HL60; HT_HG-U133A | CAPN9 HSPH1 ADCY6 ITPR2 PER2 SCN10A CCDC93 GULP1 PPP4R3B ZC3HAV1 | 1.09e-05 | 184 | 216 | 10 | 2462_UP |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; PC3; HT_HG-U133A | ADCY9 SCN10A FGF5 PIP4K2B CCDC93 DENND3 ARRB2 ZFHX2 ARHGEF26 ZNF415 | 1.65e-05 | 193 | 216 | 10 | 5764_DN |
| Drug | AC1OAGFB | URI1 SPTBN2 ADCY5 ADCY6 ADCY9 ITPR1 ITPR3 SCN10A PIP4K2B DNM1 DNM2 RASGRF1 ASAP3 AP1M2 DGKZ DNM3 CDK5 | 1.67e-05 | 539 | 216 | 17 | CID006857345 |
| Drug | U754 | 1.70e-05 | 17 | 216 | 4 | CID000062824 | |
| Drug | Trolox [53188-07-1]; Down 200; 16uM; HL60; HG-U133A | PUS3 ZBTB48 PRDM2 IFIH1 AP5Z1 ZNF468 MCF2L GLIPR1 OGDH ARRB2 | 1.97e-05 | 197 | 216 | 10 | 1734_DN |
| Drug | phytate | 2.19e-05 | 159 | 216 | 9 | CID000000890 | |
| Drug | n 1 T | 2.87e-05 | 7 | 216 | 3 | CID000448722 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 2.87e-05 | 7 | 216 | 3 | CID009547999 | |
| Drug | Br2BAPTA | 2.87e-05 | 7 | 216 | 3 | CID003081001 | |
| Drug | AC1L1EV8 | 4.55e-05 | 8 | 216 | 3 | CID000002964 | |
| Drug | Withaferin A [5119-48-2]; Up 200; 1uM; PC3; HT_HG-U133A | 6.05e-05 | 181 | 216 | 9 | 3819_UP | |
| Drug | zaprinast | 6.20e-05 | 141 | 216 | 8 | CID000005722 | |
| Drug | aminophylline | 6.58e-05 | 45 | 216 | 5 | CID000009433 | |
| Drug | 14,15-dihydroforskolin | 6.78e-05 | 9 | 216 | 3 | CID000194193 | |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; PC3; HT_HG-U133A | 8.79e-05 | 190 | 216 | 9 | 5786_UP | |
| Drug | AC1L9IND | 8.96e-05 | 2 | 216 | 2 | CID000399492 | |
| Drug | adenophostin A | 8.96e-05 | 2 | 216 | 2 | ctd:C085029 | |
| Drug | Isocaffeine | 8.96e-05 | 2 | 216 | 2 | CID000001326 | |
| Drug | adenophostin B | 8.96e-05 | 2 | 216 | 2 | CID000656722 | |
| Drug | diethyl acetylenedicarboxylate | 8.96e-05 | 2 | 216 | 2 | CID000069803 | |
| Drug | benzene 1,2,4-trisphosphate | 8.96e-05 | 2 | 216 | 2 | CID000192376 | |
| Drug | clausenamide | 9.62e-05 | 10 | 216 | 3 | CID000128412 | |
| Drug | 2',5'-dd3'-FSBA | 9.62e-05 | 10 | 216 | 3 | CID003081206 | |
| Drug | NC-5Z | 9.62e-05 | 10 | 216 | 3 | CID003035914 | |
| Drug | Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 9.90e-05 | 193 | 216 | 9 | 4343_DN | |
| Drug | Decamethonium bromide [541-22-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 9.90e-05 | 193 | 216 | 9 | 4174_UP | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; PC3; HT_HG-U133A | 1.03e-04 | 194 | 216 | 9 | 5091_UP | |
| Drug | NSC406942 | ZBTB48 PDHA1 HSPH1 GC GALNT7 ADCY5 ADCY6 ADCY9 RYR3 ITPR1 UMPS DNM1 DNM2 DNM3 TNFAIP3 PGM2 | 1.06e-04 | 565 | 216 | 16 | CID000001115 |
| Drug | 9-aminoacridine | 1.06e-04 | 79 | 216 | 6 | CID000007019 | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 1.07e-04 | 195 | 216 | 9 | 1649_DN | |
| Drug | Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; PC3; HT_HG-U133A | 1.11e-04 | 196 | 216 | 9 | 5881_DN | |
| Drug | Pipenzolate bromide [125-51-9]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.11e-04 | 196 | 216 | 9 | 4484_UP | |
| Drug | Retrorsine [480-54-6]; Down 200; 11.4uM; PC3; HT_HG-U133A | ZBTB48 AP5Z1 SCN10A DENND3 PPP4R3B ARRB2 ARHGEF26 PUS7L ZC3HAV1 | 1.11e-04 | 196 | 216 | 9 | 6601_DN |
| Drug | Viomycin sulfate [37883-00-4]; Down 200; 5.2uM; PC3; HT_HG-U133A | PIP4K2B CCDC93 SENP5 MINK1 AP1M2 DENND3 TNFAIP3 ARHGAP45 ZC3HAV1 | 1.11e-04 | 196 | 216 | 9 | 7278_DN |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; HL60; HT_HG-U133A | 1.16e-04 | 197 | 216 | 9 | 2169_DN | |
| Drug | SM-10906 | 1.16e-04 | 27 | 216 | 4 | CID006442261 | |
| Drug | Acacetin [480-44-4]; Up 200; 14uM; PC3; HT_HG-U133A | 1.20e-04 | 198 | 216 | 9 | 3767_UP | |
| Drug | Naftopidil dihydrochloride [57149-08-3]; Down 200; 8.6uM; PC3; HT_HG-U133A | SPTBN2 RABGAP1 TBC1D8B ADCY6 CALR ARRB2 ARHGEF26 ZNF415 ZC3HAV1 | 1.20e-04 | 198 | 216 | 9 | 4193_DN |
| Drug | niacin | 1.20e-04 | 198 | 216 | 9 | CID000000937 | |
| Drug | Dichlorphenamide [120-97-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.25e-04 | 199 | 216 | 9 | 5286_UP | |
| Drug | Artemisinin [63968-64-9]; Down 200; 14.2uM; HL60; HG-U133A | DCAF1 POGZ RB1CC1 EPM2AIP1 SCN10A ZNF468 CCDC93 DENND3 LIMD2 | 1.25e-04 | 199 | 216 | 9 | 1714_DN |
| Drug | Amiprilose hydrochloride [60414-06-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A | CAPN9 DCAF1 PER2 CHST10 MINK1 ARRB2 ARHGEF26 ARHGAP45 DNAJC3 | 1.25e-04 | 199 | 216 | 9 | 4119_DN |
| Drug | Iproniazide phosphate [305-33-9]; Up 200; 14.4uM; PC3; HT_HG-U133A | 1.30e-04 | 200 | 216 | 9 | 6359_UP | |
| Drug | AC1L40QM | 1.31e-04 | 11 | 216 | 3 | CID000099213 | |
| Drug | B-Mlvp | 1.31e-04 | 11 | 216 | 3 | CID000195648 | |
| Drug | AC1NY9KD | 1.31e-04 | 11 | 216 | 3 | CID005771741 | |
| Drug | R 478 | 1.31e-04 | 11 | 216 | 3 | CID000084223 | |
| Drug | 8-amino-cADPR | 1.31e-04 | 11 | 216 | 3 | CID003081323 | |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 3.32e-06 | 5 | 206 | 3 | DOID:0111223 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 3.32e-06 | 5 | 206 | 3 | DOID:11252 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 3.32e-06 | 5 | 206 | 3 | DOID:0110197 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 4.16e-06 | 93 | 206 | 7 | C1535926 | |
| Disease | mean platelet volume | HAUS6 CORO1C SLFN14 EFHC1 DSTYK SYNE2 SNX8 UMPS MCF2L GLOD5 KALRN DOCK8 CAPZA2 BTBD2 CDC42BPB CD9 CTR9 DENND2C DNM3 CATSPERB ARHGAP45 | 1.05e-05 | 1020 | 206 | 21 | EFO_0004584 |
| Disease | Hypoxic Brain Damage | 4.85e-05 | 2 | 206 | 2 | C1140716 | |
| Disease | Anoxic Encephalopathy | 4.85e-05 | 2 | 206 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 4.85e-05 | 2 | 206 | 2 | C1527348 | |
| Disease | Anoxia of brain | 4.85e-05 | 2 | 206 | 2 | C0995195 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 7.04e-05 | 12 | 206 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | collagen disease (implicated_via_orthology) | 7.04e-05 | 12 | 206 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 9.11e-05 | 13 | 206 | 3 | DOID:0112202 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | SPTBN2 MCF2L2 SNX8 UMPS PZP CCDC93 KALRN CALR SYNE1 ASAP3 PTPRU CD9 GUCY1A2 ZNF540 SPAG17 | 1.34e-04 | 702 | 206 | 15 | C0009402 |
| Disease | obesity (implicated_via_orthology) | 1.42e-04 | 215 | 206 | 8 | DOID:9970 (implicated_via_orthology) | |
| Disease | immature platelet fraction | 1.53e-04 | 114 | 206 | 6 | EFO_0009187 | |
| Disease | immature platelet measurement | 1.94e-04 | 119 | 206 | 6 | EFO_0803541 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 2.30e-04 | 43 | 206 | 4 | DOID:2476 (implicated_via_orthology) | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 2.88e-04 | 4 | 206 | 2 | cv:CN293514 | |
| Disease | platelet component distribution width | SLFN14 ZZEF1 ADCY5 DLEC1 DNM1 PREX1 KALRN DOCK8 SYNE1 CAPZA2 BTBD2 CD9 DENND2C DNM3 CATSPERB | 2.93e-04 | 755 | 206 | 15 | EFO_0007984 |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 4.78e-04 | 5 | 206 | 2 | C1450051 | |
| Disease | endodermal sinus tumor (is_marker_for) | 4.78e-04 | 5 | 206 | 2 | DOID:1911 (is_marker_for) | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 4.78e-04 | 5 | 206 | 2 | C0410190 | |
| Disease | Malignant neoplasm of breast | MCF2L2 RB1CC1 COG3 PER2 AFP SYNE2 NHS UMPS DLEC1 DEK KALRN SYNE1 PLEKHD1 LIMD2 RPRD1A GUCY1A2 TMEM39A CDC27 | 5.71e-04 | 1074 | 206 | 18 | C0006142 |
| Disease | Dyslipidemias | 6.09e-04 | 24 | 206 | 3 | C0242339 | |
| Disease | Dyslipoproteinemias | 6.09e-04 | 24 | 206 | 3 | C0598784 | |
| Disease | Emery-Dreifuss muscular dystrophy | 7.14e-04 | 6 | 206 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 7.14e-04 | 6 | 206 | 2 | C0410189 | |
| Disease | Abnormality of refraction | GC ZZEF1 BIRC6 ADCY5 ITPR2 ADAMTS9 ADAMTS20 DLEC1 PZP GLOD5 RASGRF1 DENND3 ZNF540 | 9.56e-04 | 673 | 206 | 13 | HP_0000539 |
| Disease | lethal congenital contracture syndrome (is_implicated_in) | 9.95e-04 | 7 | 206 | 2 | DOID:0060558 (is_implicated_in) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 9.95e-04 | 7 | 206 | 2 | C0751337 | |
| Disease | Unilateral agenesis of kidney | 1.32e-03 | 8 | 206 | 2 | C0266294 | |
| Disease | sialic acid-binding Ig-like lectin 12 measurement | 1.32e-03 | 8 | 206 | 2 | EFO_0802066 | |
| Disease | Polydactyly | 1.41e-03 | 117 | 206 | 5 | C0152427 | |
| Disease | Abnormality of radial ray | 1.57e-03 | 33 | 206 | 3 | C4228778 | |
| Disease | non-high density lipoprotein cholesterol measurement | REPS1 KLF14 GC DSTYK PSORS1C1 SYNE2 SNX8 XRN1 ASAP3 DGKZ MACO1 DNM3 DNAH11 | 1.60e-03 | 713 | 206 | 13 | EFO_0005689 |
| Disease | Graves Disease | 1.69e-03 | 9 | 206 | 2 | C0018213 | |
| Disease | platelet measurement | 1.75e-03 | 315 | 206 | 8 | EFO_0005036 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.90e-03 | 75 | 206 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | Leigh Syndrome due to Mitochondrial Complex V Deficiency | 2.02e-03 | 36 | 206 | 3 | C1850600 | |
| Disease | Necrotizing encephalopathy, infantile subacute, of Leigh | 2.02e-03 | 36 | 206 | 3 | C2931891 | |
| Disease | Leigh Syndrome due to Mitochondrial Complex III Deficiency | 2.02e-03 | 36 | 206 | 3 | C1850598 | |
| Disease | Leigh Syndrome Due To Mitochondrial Complex II Deficiency | 2.02e-03 | 36 | 206 | 3 | C1850597 | |
| Disease | Leigh Syndrome due to Mitochondrial Complex IV Deficiency | 2.02e-03 | 36 | 206 | 3 | C1850599 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 2.10e-03 | 10 | 206 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | vesicular integral-membrane protein VIP36 measurement | 2.10e-03 | 10 | 206 | 2 | EFO_0022012 | |
| Disease | LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY | 2.19e-03 | 37 | 206 | 3 | C1838951 | |
| Disease | Other specified cardiac arrhythmias | 2.56e-03 | 11 | 206 | 2 | C0348626 | |
| Disease | Nodal rhythm disorder | 2.56e-03 | 11 | 206 | 2 | C0264893 | |
| Disease | Ectopic rhythm | 2.56e-03 | 11 | 206 | 2 | C1399226 | |
| Disease | CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder) | 2.56e-03 | 11 | 206 | 2 | C2748542 | |
| Disease | post-traumatic stress disorder symptom measurement | 2.64e-03 | 82 | 206 | 4 | EFO_0008535 | |
| Disease | Inherited neuropathies | 2.74e-03 | 40 | 206 | 3 | C0598589 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 3.06e-03 | 12 | 206 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | age of onset of multiple sclerosis | 3.06e-03 | 12 | 206 | 2 | OBA_2001029 | |
| Disease | Brugada Syndrome 1 | 3.60e-03 | 13 | 206 | 2 | C4551804 | |
| Disease | Uterine leiomyoma | 3.84e-03 | 91 | 206 | 4 | HP_0000131 | |
| Disease | serum non-albumin protein measurement | 4.02e-03 | 361 | 206 | 8 | EFO_0004568 | |
| Disease | platelet-to-lymphocyte ratio | 4.16e-03 | 363 | 206 | 8 | EFO_0008446 | |
| Disease | orotic acid measurement | 4.18e-03 | 14 | 206 | 2 | EFO_0010516 | |
| Disease | Leigh Disease | 4.34e-03 | 47 | 206 | 3 | C0023264 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.37e-03 | 152 | 206 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | coronary artery disease | REPS1 CORO1C KLF14 IGSF10 IFIH1 ASAP2 DSTYK FGF5 UMPS PIP4K2B DLEC1 MCF2L PREX1 DOCK8 PTPRU GUCY1A2 ARHGEF26 | 4.44e-03 | 1194 | 206 | 17 | EFO_0001645 |
| Disease | S-warfarin to R-warfarin ratio measurement | 4.48e-03 | 95 | 206 | 4 | EFO_0803331 | |
| Disease | atrial fibrillation | 4.73e-03 | 371 | 206 | 8 | EFO_0000275 | |
| Disease | hepatoblastoma (is_marker_for) | 4.80e-03 | 15 | 206 | 2 | DOID:687 (is_marker_for) | |
| Disease | Sinus Node Dysfunction (disorder) | 4.80e-03 | 15 | 206 | 2 | C0428908 | |
| Disease | Paroxysmal atrial fibrillation | 4.87e-03 | 156 | 206 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 4.87e-03 | 156 | 206 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 4.87e-03 | 156 | 206 | 5 | C2585653 | |
| Disease | vascular endothelial function measurement | 5.18e-03 | 99 | 206 | 4 | EFO_0803369 | |
| Disease | venous thromboembolism | 5.25e-03 | 460 | 206 | 9 | EFO_0004286 | |
| Disease | Atrial Fibrillation | 5.42e-03 | 160 | 206 | 5 | C0004238 | |
| Disease | Congenital total cataract | 5.46e-03 | 16 | 206 | 2 | C0266539 | |
| Disease | 2-hydroxyglutarate measurement | 5.46e-03 | 16 | 206 | 2 | EFO_0021506 | |
| Disease | preeclampsia, hypertension, pregnancy-induced | 5.46e-03 | 16 | 206 | 2 | EFO_0000668, MONDO_0024664 | |
| Disease | brain measurement, neuroimaging measurement | CORO1C POLR2M RABGAP1 ADAMTS9 DSTYK ADAMTS20 DENND3 CCDC88C CATSPERB DNAH11 | 5.53e-03 | 550 | 206 | 10 | EFO_0004346, EFO_0004464 |
| Disease | epilepsy (implicated_via_orthology) | 5.85e-03 | 163 | 206 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Hypermetropia | 5.96e-03 | 103 | 206 | 4 | HP_0000540 | |
| Disease | body fat percentage, type 2 diabetes mellitus | 6.16e-03 | 17 | 206 | 2 | EFO_0007800, MONDO_0005148 | |
| Disease | Limb Deformities, Congenital | 6.16e-03 | 17 | 206 | 2 | C0206762 | |
| Disease | immature platelet count | 6.59e-03 | 106 | 206 | 4 | EFO_0803544 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EKAIKFYREALVHCE | 901 | Q7Z4L5 | |
| NAKRAYAEAVHLDKC | 356 | Q96RK4 | |
| NPEEKKCFDLVTHNR | 356 | Q8TDY4 | |
| VKFHQCVRLSRFDND | 236 | Q9Y6Q5 | |
| EFHEKLLNTLCRKTD | 1326 | Q9NR09 | |
| QKFSHAVAFSDCREK | 926 | Q9H7T0 | |
| ELFARFDKLAAENHC | 406 | O43306 | |
| HSDKKLTLVFEFCDQ | 71 | Q00535 | |
| HSFEFLINEPNKCEK | 61 | Q9Y5Z6 | |
| NKRHCRSFDFLEALD | 46 | C9J069 | |
| DVNKCEIARFFKLHE | 326 | Q9ULV4 | |
| CHLAKLFDSIADLQF | 1651 | Q96DT5 | |
| KECEFNKNFRLILHT | 3571 | Q96DT5 | |
| IERKLFDETCTEHAK | 226 | Q8IU99 | |
| FDETCTEHAKAFAKV | 231 | Q8IU99 | |
| CEASKKFFIELEARH | 491 | Q96DR7 | |
| HQAREIQDEELKKFC | 11 | O43299 | |
| FHQFLEAKGQEKTCR | 41 | Q96G46 | |
| ELFARFDKLAAENHC | 496 | O95622 | |
| CKDFEVDSHIKDFAA | 136 | A2RUS2 | |
| KHKADSLDCSRFLVE | 726 | Q14692 | |
| RECLKLDQDHKRCFA | 246 | Q13217 | |
| FKEDCHQKIDDLFSG | 186 | P60033 | |
| EIRAFCAKSLEEKSH | 146 | P32121 | |
| EDFKRHRFDKAINCS | 136 | O94823 | |
| DFREKQCSDFNGKHL | 616 | P59510 | |
| EKVASIFDFKACHDQ | 336 | O75355 | |
| NIRDEVAFHTAKCEK | 1056 | Q5JR59 | |
| IEKCEAKFHLDRVEN | 211 | O75901 | |
| CNRAKLFRFDVESKE | 1196 | P49792 | |
| SLFTDLVAEKDLFHC | 71 | P20742 | |
| LTCDEYEKKQHIFLR | 251 | Q14571 | |
| VRLFHAEQEKFLTCD | 241 | Q14573 | |
| VADSVRFQVDKCFKH | 481 | Q6IE37 | |
| KEDLCHFRTFVQKEQ | 816 | Q8TDY2 | |
| RELFKQNFEDLHCKF | 681 | Q9Y3P9 | |
| GEVFFLKECTKRHTD | 316 | A1A4S6 | |
| RKCNEVKDDDLFHSY | 376 | Q8NEZ5 | |
| QDKRSDHVKFCKYAA | 796 | Q9Y4B6 | |
| DHVKFCKYAAELIER | 801 | Q9Y4B6 | |
| ELSENKLLIFSEHFC | 516 | A4D1F6 | |
| EDFIKDCVRIHNKFR | 31 | P48060 | |
| QRCEDHDKARFLVAK | 411 | Q92619 | |
| FVIRKDKCHFNEILK | 136 | Q96M61 | |
| ERLVADKLIFHNSCF | 51 | Q9BT23 | |
| EAAVQLSFDKHCDRK | 216 | Q9NWZ8 | |
| TIQHSFFCRLTEDKK | 1846 | Q14643 | |
| FLDRCNHLKRSEKES | 446 | Q9NXD2 | |
| KALCFGDQKFNLHEV | 71 | A6NK44 | |
| AEFLHCKGKKFTDFE | 81 | Q05193 | |
| EEKKCFDLISHDRTY | 361 | O43150 | |
| FDEKLVEHFCAEFKT | 236 | Q92598 | |
| ENKFHVKFADHVVCE | 476 | Q5JUK3 | |
| ELTRCKEKLHDVDFY | 331 | Q9P219 | |
| AEFLHCKGKKFTDFD | 81 | Q9UQ16 | |
| KDLKNFHVDLCRPFA | 141 | Q8N5G2 | |
| QLQHFEHDFCKAKLA | 321 | Q86YR7 | |
| EHDFCKAKLALDNLL | 326 | Q86YR7 | |
| RFFAKLVTDKCVDLD | 436 | Q5JST6 | |
| HCKRDAFSDAKFVEF | 216 | O15055 | |
| KKCHEVERHFFEITD | 506 | Q6N069 | |
| AKLFCEDKSSHLVFI | 631 | Q5KU26 | |
| KNCTLELKGLFHFEE | 2011 | Q5H8C1 | |
| EELECFDQDKKRSIH | 531 | Q6UY01 | |
| HKDFFLAELEKCIQE | 1986 | O60229 | |
| EFSSCLQKAHEFLRL | 406 | P48449 | |
| EDLKKYCFHRSVNRE | 231 | Q96G03 | |
| LKLHESVKNNFEFCE | 341 | Q9H0R1 | |
| SKERKLREHSENFCK | 641 | Q9Y5S2 | |
| NTSEDKCEKDFFLKH | 481 | Q5MIZ7 | |
| LRDTKHDFVFLDICI | 136 | Q8IXY8 | |
| AEFLHCKSKKFTDFD | 81 | P50570 | |
| EHGRCLEDLEFKFKE | 426 | O95613 | |
| KREGSCSDFQFKLHE | 491 | Q8WVV4 | |
| RETQKFFRDIKCSHN | 46 | Q6XUX3 | |
| DEFFKKCRVIPSQEH | 236 | O14745 | |
| KTCREEQKNLHFFAP | 231 | Q9UHY1 | |
| RCHNLVDVFFAAKTL | 1401 | Q92729 | |
| FIISEAHVCKDSDLF | 401 | Q6ZMV5 | |
| HLDVFFQEEFSCSIK | 231 | Q96QZ0 | |
| VKHKSFLTAEDCFEL | 156 | P13674 | |
| RFCKDDIKHGNTFQI | 246 | Q9NR21 | |
| HASAKFTDDCKFRER | 151 | P12034 | |
| CEEAFARSKDEKILH | 566 | Q02218 | |
| LKSQEQEFKAHCREE | 396 | Q567U6 | |
| KRDFRDEQCAHFDGK | 646 | Q9P2N4 | |
| CPDAIKEVFDNKFHI | 181 | P21926 | |
| FRKQVLHGKDFQVDC | 2046 | Q6WRI0 | |
| RKHIEFSFQPVCKAE | 196 | Q9NZH6 | |
| LQCRDLVDEAKKFHL | 246 | Q53G59 | |
| DDRTCKHLLNEALKY | 246 | Q9NXS3 | |
| HLSEEKNFKESCLFD | 136 | A0A1B0GVN3 | |
| DSVCKIHEEKDFIAF | 346 | P51878 | |
| YDVKERKKISENFHC | 291 | Q8NF50 | |
| RKKISENFHCDLNSD | 296 | Q8NF50 | |
| LEIDRDTKKCAFRTH | 296 | Q16658 | |
| ELAKENIKCFFEGSH | 231 | Q5R3K3 | |
| AAAFDHICTFEVKLN | 406 | Q7L775 | |
| KKDVDRHLKSACEQF | 686 | Q96JB2 | |
| SELKKFREDHNCKSF | 496 | Q86SF2 | |
| QKLCEIERIHFFLSK | 86 | P35659 | |
| ILAAFDNFKEVCKEL | 286 | Q8IVF7 | |
| DNFKEVCKELHRFEK | 291 | Q8IVF7 | |
| HRISFCADDKTDKRI | 96 | Q9UBP9 | |
| LTRDCEHFKAERKFI | 106 | O95395 | |
| KERVCAEHLRKYNEA | 596 | Q9BYX4 | |
| CEFHEAEKLYKNILR | 511 | Q6PD62 | |
| LINKDIRCKDDEFTH | 156 | P27797 | |
| RFKNIREKTDAHFVD | 716 | O60503 | |
| IHFSKSENCKDVFIE | 646 | Q02410 | |
| RSKRKSFEFEDIQHF | 266 | Q68D51 | |
| FDISCDKDNKRFALL | 121 | P49913 | |
| KEDCHTERNTRKFLY | 701 | Q6ZN28 | |
| KGTINFLHADCDKFR | 291 | Q9BS26 | |
| FFQECQRKLDHKLSL | 746 | O15068 | |
| HDIILAAFDNFKEVC | 286 | O95466 | |
| KDHSCKDNIREAFQI | 571 | Q5JVL4 | |
| FDQKSDTEFRKHCCE | 81 | Q7Z4H7 | |
| DCDKKFTRSDELARH | 231 | Q8TD94 | |
| HLEDVFQLFKFCSVL | 856 | Q9H583 | |
| EVALVKFKSHRFADC | 276 | Q5T6L9 | |
| EAAKRNDFCKLQELH | 796 | Q13574 | |
| IFDSFAKLKAAIAEC | 51 | P0CAP2 | |
| EAHCVEFLKKNLRAD | 206 | Q9BX70 | |
| FKDFKAHFDKVEICN | 321 | O14815 | |
| HQEADFCLRIFSEKK | 476 | O14815 | |
| CKFEEKVSSEHFIQS | 1486 | Q9C0D2 | |
| CRKKLAEFEDELDHT | 256 | Q9Y238 | |
| CFFHSVLLERKKFLQ | 3986 | Q9P225 | |
| EFNLVCDRKHLKDTT | 126 | Q9Y226 | |
| EFFELSDLLLHKKNC | 51 | Q9NSC2 | |
| FFSISEFLEHKKNCT | 81 | Q9UJQ4 | |
| CFSLQREHDIAIKFF | 576 | P30260 | |
| AFDKLDAHVERVDCK | 616 | O43933 | |
| ERKHVDGCAIFFKTE | 276 | Q9ULM6 | |
| DKFICNDDFKHKLFR | 806 | Q13620 | |
| AFNFVKSCKEDVHVF | 51 | Q96LW4 | |
| FSDDKFIFHKDLCQA | 526 | P02771 | |
| FCVQLFKDKTDLSEH | 1166 | Q13029 | |
| SQHNRFVLDCKDKEP | 26 | P68402 | |
| LKFLCERNDKVFFAS | 1296 | Q8N4C8 | |
| RCDTHKVLKFEDCFE | 351 | P33402 | |
| DSDFLAKLHCIRQAF | 381 | Q8NAN2 | |
| IHEDFIQSCFDRLKA | 811 | Q93008 | |
| PVKDTAHDFRAKCRN | 136 | Q9UPQ4 | |
| SDFKNLQCFLHEEEK | 181 | O00635 | |
| LFHEEETKAKRDCND | 441 | Q9BZE2 | |
| DLCALAFKVLHDKQR | 366 | Q969S9 | |
| SEEFHKLCFASRAIK | 886 | P0C7P3 | |
| DEFCAAFHLVVARKN | 341 | Q96D71 | |
| IREEIKCDFEFKAKH | 161 | O94763 | |
| EFLNCKLATRAKDFL | 196 | Q9Y5X2 | |
| LKVKFFDLERENACA | 411 | Q8N7P1 | |
| LVSRKHFKEDFDKAC | 4561 | Q8NF91 | |
| NEVEHKIKFCRQFHE | 2936 | Q8WXH0 | |
| SRKVDALDHFQKCFL | 391 | P04053 | |
| HLEKNSTFDVKNRCD | 1216 | Q6T4R5 | |
| LCHLVSEEEAFDFFK | 206 | Q9H0K6 | |
| ERNVFKFICDASSLH | 226 | Q9BSH4 | |
| HLKNLQSDLKRCFDF | 1256 | Q8IVG5 | |
| KCRLQFLFAKDKIEH | 651 | Q7Z3K3 | |
| KHFVCQKVKLFRASE | 26 | P78356 | |
| ELSLSCKKERDFLHE | 596 | P0CG39 | |
| HFEFRNICDTKLESI | 916 | Q8TCU6 | |
| FRETDVAKKISHICF | 6 | O14802 | |
| QFELCHRKDLDLAKV | 906 | Q9C0A6 | |
| KEGERQCFLFSKHLI | 486 | Q13972 | |
| LCLSEREKKNLHDIF | 491 | Q6Q759 | |
| FKELCASFFQRVKKH | 51 | Q8IY92 | |
| CDHLKESLFQYEREK | 81 | Q8NF67 | |
| KNRICFKFDHLRKEA | 91 | P47755 | |
| SKFVLDRIFVCDKHK | 106 | O43529 | |
| ERKHVDGCAIFFKTE | 276 | Q96LI5 | |
| FFLFDHQLVSCKKDL | 476 | Q96N96 | |
| YDCKDEFNKQDHRIV | 836 | Q96JI7 | |
| FTDFSCKHPRELREK | 3211 | A4UGR9 | |
| FKEAFHDISHCLKAQ | 101 | Q5JXX7 | |
| EAFKHRGEKLFVCEE | 426 | P10074 | |
| FLLKQDCDTFDLHEK | 121 | Q8N8J6 | |
| EECGKAFNHFSALRK | 316 | A8MXY4 | |
| EECGKAFNHFSALRK | 596 | A8MXY4 | |
| LDRKICSNHKLLFED | 291 | I1YAP6 | |
| SDHEYCREKNLLKAV | 126 | Q96HI0 | |
| RFFSPELKQEHESKC | 756 | Q9ULJ3 | |
| CDKGFFSRLELTQHK | 276 | Q8NDQ6 | |
| ECDKAFNKFSTLITH | 541 | Q03936 | |
| EECDKAFHFKSILER | 301 | Q86XN6 | |
| VRHLKKCYDDQTLEE | 1686 | Q9C0A1 | |
| ANDATFEIKKCDLHR | 31 | P08559 | |
| KCFIEAQNQRFHEAK | 676 | P21580 | |
| ERDLCLSKFVHKSFV | 306 | P50453 | |
| DLLDFESLKKCNAHY | 221 | O15020 | |
| KTAFRFHEVKDFEQL | 366 | Q0IIM8 | |
| VSHLKRFFEECIRNA | 396 | A6NEE1 | |
| DFLRCQKEALAEKEH | 246 | Q96P16 | |
| QDQILEKFRKSAEHC | 121 | Q9UJT0 | |
| DDNKRQHPCLVEFSK | 896 | Q15413 | |
| DKIHCLDILFAFTKN | 1796 | Q9Y5Y9 | |
| CLKADFNHRIKEVLF | 276 | Q9NV64 | |
| FFHKVDNLICRELNK | 46 | Q9BX26 | |
| EDSADLKCQLHFAKE | 141 | O94964 | |
| SKEFHLAATQDDCRK | 66 | Q9UIG5 | |
| PDQCEKFRKAFSHLT | 141 | Q96SK3 | |
| RDYEKNKVCKEFSHL | 21 | P02774 | |
| NKVCKEFSHLGKEDF | 26 | P02774 | |
| QCHSENEAKEKAALF | 1486 | Q8IZH2 | |
| DQLFREHLLKTDCKS | 246 | Q8IZM8 | |
| LAKCHEFLIFEDRKF | 301 | P11172 | |
| ECDKVFSQKSTLERH | 431 | Q8N4W9 | |
| FFKAALCHFIVDELN | 206 | Q9H115 | |
| VIHEDFIQSCFDRLK | 811 | O00507 | |
| ECKECEKAFSNRAHL | 316 | Q7Z398 | |
| EFCFREIKKKIHDFD | 131 | Q09FC8 | |
| VEEALFVKRCKFHVS | 141 | Q8TF45 | |
| SSSDKFCAEEHFKRF | 606 | O43149 | |
| EECEKVFSRKSHLER | 386 | P17035 | |
| EFRKNCDKKTLFDHR | 286 | Q9Y2H8 | |
| CKYSHEVLSEENFKV | 106 | Q7Z2W4 | |
| CFQKIGKDIHDFEFQ | 101 | A6NHJ4 | |
| EVRHQKFFDLFEKCD | 401 | O43314 | |
| LCHQTLFIFDEAEKL | 226 | Q9H497 | |
| EECDKVFSRKSHLER | 386 | Q5VIY5 | |
| FIQHECFQKSEARKR | 376 | Q99959 | |
| SECEKTFRKQAHLSE | 221 | Q96CX3 | |
| VEHAAVKNDTERKFC | 931 | Q9P2D8 | |
| FCKFRTFEEKDIELH | 316 | Q5BKZ1 | |
| RDDETIKEHLCKLTF | 251 | Q9H6V9 | |
| KALASDDHCNLKFEA | 1611 | P52179 |